MHLW 2009 Budget Requests ¥1.4 Billion To Strengthen PDMA Safety Measures
This article was originally published in PharmAsia News
Executive SummaryThe Ministry of Health, Labor and Welfare released Aug. 26 a budget request for fiscal year 2009 of ¥22.85 trillion, an ¥829.2 billion and 3.8 percent increase compared to FY 2008's initial budget. The budget allocates ¥48.2 billion to stock up on flu drugs such as Tamiflu (oseltamivir)and Relenza (zanamavir) and pre-pandemic vaccines, and to develop pandemic vaccines. ¥33.2 billion is designated to develop new drugs in the areas of cancer, mental disorder, intractable and rare diseases and regenerative medicine. To boost safety measures in drugs and medical devices, ¥1.4 billion is allocated to the Pharmaceutical and Medical Device Agency to increase staff, and ¥900 million to the PDMA in establishing a consulting system to promote Japan-U.S.-Europe joint clinical trials and concurrent reviews for medical device. (Click here for more - Japanese language
You may also be interested in...
Political tensions between Switzerland and the EU have led to concerns about the future status of the only Swiss medtech notified body, SQS. Here’s what SQS board member Daniel Taddeo said about the situation.